Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 4/11/14 → 11/28/18 |
Funding
- Baxter Healthcare Co: $26,363.00
BAX855 Extension-A Phase 3B Continuation Study of the Safety and Efficacy of PEGylated Recombinant Factor VII in Prophylaxis of Bleeding in Previously Treated Patients with Severe Hemophilia A
- Radulescu, Vlad (PI)